Jeffrey Gerald Mifek bought $10k of FEMY
Chief Clinical-Medical Affairs at FEMASYS INC. 3,125 shares at an average of $3.20, traded Aug 7, 2026, filed Aug 11, 2026.
Score components
- +15RoleOfficer
- 0Trade size$10k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- +15Cluster5 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-26-032336, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | POpen-market purchase Common Stock | +3,125 | $3.20 | $10k | 3,125 | Aug 11, 2026 |
| Aug 7, 2026 | AGrant or award Common Stock Purchase Warrantderivative | +3,125 | - | - | 3,125 | Aug 11, 2026 |
| Aug 7, 2026 | AGrant or award Common Stock Purchase Warrant (Milestone)derivative | +3,125 | - | - | 3,125 | Aug 11, 2026 |
Related signals
Other insiders at FEMASYS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | FEMASYS INC | John Charles Canning Chief Operating Officer | $14k 4,375 shares | - | |
| 52Moderate | FEMASYS INC | Dov Elefant Chief Financial Officer | $50k 15,625 shares | - | |
| 55Moderate | FEMASYS INC | Kathy Lee-Sepsick Chief Executive Officer | $50k 15,625 shares | - | |
| 38Weak | FEMASYS INC | Jeremy Alexander Sipos Chief Technology Officer | $10k 3,125 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.